IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients

Clin Exp Immunol. 1998 Jun;112(3):528-32. doi: 10.1046/j.1365-2249.1998.00589.x.

Abstract

In the present study we evaluated in vitro immunoglobulin production from IgAD individuals and healthy controls. Peripheral blood mononuclear cells (PBMC) from IgAD and controls were cultured with anti-CD40 MoAb presented on a CDw32-transfected fibroblast cell line (CD40 system) in the presence of IL-10, IL-2, IL-4, transforming growth factor-beta (TGF-beta) alone as well as of IL-10 in combination with each of the other three cytokines. Only IL-10 added alone induced significant changes in baseline immunoglobulin production; marked increases in median supernatant levels of all three isotypes were observed in both groups. The most striking finding of this study was the synergizing effect of IL-4 on IgA production in the IgAD group when added with IL-10; median IgA supernatant level increased to a value superimposable on that found in the normal controls which remained about the same as when stimulated with IL-10 alone. The synergic effect of IL-4 and IL-10 was specific to the IgA isotype.

MeSH terms

  • Adolescent
  • Adult
  • CD40 Antigens / immunology
  • Child
  • Child, Preschool
  • Drug Synergism
  • Female
  • Fibroblasts / immunology
  • Humans
  • IgA Deficiency / drug therapy
  • IgA Deficiency / immunology*
  • Interleukin-10 / immunology
  • Interleukin-10 / pharmacology*
  • Interleukin-10 / therapeutic use
  • Interleukin-2 / immunology
  • Interleukin-2 / pharmacology
  • Interleukin-4 / immunology
  • Interleukin-4 / pharmacology*
  • Interleukin-4 / therapeutic use
  • Male
  • Middle Aged
  • Transfection
  • Transforming Growth Factor beta / immunology
  • Transforming Growth Factor beta / pharmacology

Substances

  • CD40 Antigens
  • Interleukin-2
  • Transforming Growth Factor beta
  • Interleukin-10
  • Interleukin-4